Mechanism of the slow induction of apolipoprotein A-I synthesis by retinoids in cynomolgus hepatocytes: Involvement of retinoic acid and retinoid X receptors

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2273-2280

  Kaptein, Allard ^a,b   Neele, Diana M ^a   Twisk, Jaap ^a   Hendriks, Henk F J ^a   Kooistra, Teake ^a   Princen, Hans M G ^a  

^a TNO   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Apolipoprotein A I; Cynomolgus hepatocytes; MRNA; RAP; Receptor selective ligands; Retinoids; RXR; Transcriptional regulation

Indexed keywords

APOLIPOPROTEIN A1; RETINOIC ACID; RETINOID X RECEPTOR;

ANIMAL CELL; ARTICLE; LIPOGENESIS; LIPOPROTEIN METABOLISM; LIVER CELL; LIVER METABOLISM; MONKEY; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; APOLIPOPROTEIN A-I; BENZOATES; BLOTTING, NORTHERN; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; LIVER; MACACA FASCICULARIS; MALE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0030691944     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gordon, D. J., and B. M. Rifkind. 1989. High density lipoprotein: the clinical implications of recent studies. N. Engl. J. Med. 351: 1311-1316.
2. Breslow, J. L. 1989. Familial disorders of high density lipoprotein metabolism. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1251-1266.
3. Glueck, C. J., P. Gartside, R. W. Fallat, J. Sielski, and P. M. Steiner. 1976. Longevity syndromes: familial hypobeta and familial hyperbeta and familial hyperalpha lipoproteinemia. J. Lab. Clin. Med. 88: 941-957.
4. Brunzell, J. D., A. D. Sniderman, J. J. Albers, and P. O. Kwiterovich, Jr. 1984. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 4: 79-83.
5. Saku, K., P. S. Gartside, B. A. Hynd, and M. L. Kashyap. 1985. Mechanism of action of gemfibrozil on lipoprotein metabolism. J. Clin. Invest. 75: 1702-1712.
6. Reichl, D., and N. E. Miller. 1989. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 9: 785-797.
7. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
8. Kaptein, A., E. C. M. de Wit, and H. M. G. Princen. 1993. Retinoids stimulate apoA-I synthesis by induction of gene transcription in primary hepatocyte cultures from cynomolgus monkey (Macaca fascicularis). Arterioscler. Thromb. 13: 1505-1514.
9. Giller, T., U. Hennes, and H. J. Kempen. 1995. Regulation of human apolipoprotein A-I expression in Caco-2 and HepG2 cells by all-trans and 9-cis retinoic acids. J. Lipid Res. 36: 1021-1028.
10. Haghpassand, M., and J. B. Moberly. 1995. 9-cis Retinoic acid increases apolipoprotein A-I secretion and mRNA expression in HcpG2 cells. Atherosclerosis. 117: 199-207.
11. Berthou, L., B. Staels, I. Saldicco, K. Berthelot, J. Casey, J. C. Fruchart, P. Denèfle, and D. Branellec. 1994. Opposite in vitro and in vivo regulation of hepatic apolipoprotein A-I gene expression by retinoic acid. Arterioscler. Thromb. 14: 1657-1664.
12. Bershad, S., A. Rubinstein, J. R. Paterniti, Jr., N-A. Le, S. C. Poliak, B. Heller, H. N. Ginsberg, R. Fleischmajer and W. V. Brown. 1985. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N. Engl. J. Med. 313: 981-985.
13. Neele, A. M., R. Buytenhek, A. E. Wallnöfer, J. M. T. Van Griensven, T. Kooistra, and H. M. G. Princen. 1996. Effects of oral isotretinoin (13-cis-retinoic acid) on lipoprotein [a]and apolipoproteins in healthy volunteers. (Poster paper). Eur. J. Clin. Nutr. 50: suppl 3 S72.
14. Stunnenberg, H. G. 1993. Mechanisms of transactivation by retinoic acid receptors. BioEssays. 15: 309-315.
15. Pfahl, M., and Chytil F. 1996. Regulation of metabolism by retinoic acid and its nuclear receptors. Annu. Rev. Nutr. 16: 257-283.
16. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954.
17. Levin, A. A., L. J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, C. E. Kratzeisen, M. Rosenberger, A. Lovey, and J. F. Grippo. 1992. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature. 355: 359-361.
18. Heyman, R. A., D. J. Mangelsdorf, J. A. Dyck, R. B. Stein, G. Eichele, R. M. Evans, and C. Thaller. 1992. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68: 397-406.
19. Rottman, J. N., R. L. Widom, B. Nadal-Ginard, V. Mahdavi and S. K. Karathanasis. 1991. A retinoic acid-responsive element in the apolipoprotein A-I gene distinguishes between two different retinoic acid responsive pathways. Mol. Cell. Biol. 11: 3814-3820.
20. Zhang, X., J. Lehmann, B. Hoffmann, M. I. Dawson, J. Cameron, G. Graupner, T. Hermann, P. Tran, and M. Pfahl. 1992. Homodinier formation of retinoid X receptor induced by 9-cis retinoic acid. Nature. 358: 587-591.
21. Strickland, S., T. R. Breitman, F. Frickel, A. Nürrenbach, E. Hädicke, and M. B. Sporn. 1983. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res. 43: 5268-5272.
22. Boehm, M. F., L. Zhang, B. A. Badea, S. K. White, D. E. Mais, E. Berger, C. M. Suto, M. E. Goldman, and R. A. Heyman. 1994. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem. 137: 2930-2941.
23. Barua, A. B., R. O. Batres, and J. A. Olson. 1989. Characterization of retinyl β-glucuronide in human blood. Am. J. Clin. Nutr. 50: 370-374.
24. Eckhoff, C., and H. Nau. 1990. Identification and quantification of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J. Lipid Res. 31: 1445-1454.
25. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162: 156-159.
26. Hamada, K., S. L. Gleason, B. Z. Levi, S. Hirschfeld, E. Appella, and K. Ozato. 1989. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc. Natl. Acad. Sci. USA. 86: 8289-8293.
27. Twisk, J., E. M. Lehmann, and H. M. G. Princen. 1993. Differential feedback regulation of cholesterol 7α-hydroxylase mRNA and transcriptional activity by rat bile acids in primary monolayer cultures of rat hepatocytes. Biochem. J. 290: 685-691.
28. de Thé, H., A. Marchio, P. Tiollais, and A. Dejean. 1989. Differential expression and ligand regulation of the retinoic acid receptor α and B genes. EMBO J. 8: 429-433.
29. Hu, L., and L. J. Gudas. 1990. Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor α, β, γ mRNAs in F9 teratocarcinoma cells. Mol. Cell. Biol. 10: 391-396.
30. Kato, S., H. Mano, T. Kumazawa, Y. Yoshizawa, R. Kojima, and S. Masushiga. 1992. Effect of retinoid status on α, β, γ retinoic acid receptor mRNA levels in various rat tissues. Biochem. J. 286: 755-760.
31. de Thé, H., M. D. M. Vivanco Ruiz, P. Tiollais, H. Stunnenberg, and A. Dejean. 1990. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature. 343: 177-180.
32. Widom, R. L., M. Rhee, and S. K. Karathanasis. 1992. Repression by ARP-1 sensitizes apolipoprotein A-I gene responsiveness to RXRα and retinoic acid. Mol. Cell. Biol. 12: 3380-3389.
33. Chen, J-Y., J. Clifford, C. Zusi, J. Starrett, D. Tortolani, J. Ostrowski, P. R. Reczek, P. Chambon, and H. Gronemeyer. 1996. Two distinct actions of retinoid-receptor ligands. Nature. 382: 819-822.
34. Roy, B., R. Taneja, and P. Chambon. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol. 15: 6481-6487.
35. Taneja, R., B. Roy, J-L. Plassar, C. F. Zusi, J. Ostrowski, P. R. Reczek, and P. Chambon. 1996. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RARβ2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Natl. Acad. Sci. USA. 93: 6197-6202.